Search results
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 3 days agoNotable data include an oral presentation on biomarker analyses from the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial (NCT02811861), which evaluated lenvatinib (LENVIMA®), the orally ...
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)
Guru Focus· 5 days agoInc (EXEL, Financial), executed a sale of 27,280 shares of the company. Following this transaction, the insider now owns 5,445 shares of Exelixis Inc. Exelixis Inc is a biotechnology company ...
Nimbus reports positive data from Phase I/II solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAccording to the results, 16.7% of response-evaluable patients experienced clinical benefits from...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 3 days agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 days agoThe company also has other high-impact clinical programs in later stages of development which are intended to treat conditions like renal cell ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 7 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 4 days agoPer BMY, this is the first phase III study of the subcutaneous formulation of nivolumab to evaluate...
Kidney Cancer Immunotherapy Response Linked to Signature Reflecting HLA, Tumor Immune Activity
GenomeWeb News· 5 days agoResearchers found an immune checkpoint blockade response signature in renal cell carcinoma that reflects tumor immune activity influenced by human leukocyte antigen features.
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 4 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 11 hours agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...